Literature DB >> 8842498

A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction).

B A Teicher1.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8842498     DOI： 10.1007/bf00437479

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN： 0167-7659            Impact factor:   9.264


× No keyword cloud information.
  297 in total

Review 1.  The heparin-binding (fibroblast) growth factor family of proteins.

Authors:  W H Burgess; T Maciag
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

2.  Treatment of haemangioendotheliomas with alpha interferon.

Authors:  P J Orchard; C M Smith; W G Woods; D L Day; L P Dehner; R Shapiro
Journal:  Lancet       Date:  1989-09-02       Impact factor: 79.321

3.  Regulation of matrix metalloproteinases - their role in tumor invasion and metastasis.

Authors:  D Cottam; R Rees
Journal:  Int J Oncol       Date:  1993-06       Impact factor: 5.650

4.  Antitumor effect of the angiogenesis inhibitor agm-1470 and its combination effect with tamoxifen in dmba induced mammary-tumors in rats.

Authors:  M Toi; Y Yamamoto; T Imazawa; T Takayanagi; K Akutsu; T Tominaga
Journal:  Int J Oncol       Date:  1993-09       Impact factor: 5.650

5.  Anti-angiogenesis: new concept for therapy of solid tumors.

Authors:  J Folkman
Journal:  Ann Surg       Date:  1972-03       Impact factor: 12.969

Review 6.  Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease.

Authors:  K D Setchell; S P Borriello; P Hulme; D N Kirk; M Axelson
Journal:  Am J Clin Nutr       Date:  1984-09       Impact factor: 7.045

7.  Fibronectin-degrading proteases from the membranes of transformed cells.

Authors:  J M Chen; W T Chen
Journal:  Cell       Date:  1987-01-30       Impact factor: 41.582

8.  Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo.

Authors:  T Yanase; M Tamura; K Fujita; S Kodama; K Tanaka
Journal:  Cancer Res       Date:  1993-06-01       Impact factor: 12.701

9.  Genistein, a dietary-derived inhibitor of in vitro angiogenesis.

Authors:  T Fotsis; M Pepper; H Adlercreutz; G Fleischmann; T Hase; R Montesano; L Schweigerer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

10.  Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression.

Authors:  Z Werb; P M Tremble; O Behrendtsen; E Crowley; C H Damsky
Journal:  J Cell Biol       Date:  1989-08       Impact factor: 10.539
View more
  34 in total

Review 1.  Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease.

Authors:  Shom Goel; Andus Hon-Kit Wong; Rakesh K Jain
Journal:  Cold Spring Harb Perspect Med       Date:  2012-03       Impact factor: 6.915

2.  Normalizing Tumoral Vessels to Treat Cancer: An Out-of-the-Box Strategy Involving TIE2 Pathway.

Authors:  Juan Fueyo; Mohammad B Hossain; Teresa Nguyen; Candelaria Gomez-Manzano
Journal:  Transl Cancer Res       Date:  2017-03       Impact factor: 1.241

3.  Pharmacodynamic study using FLT PET/CT in patients with renal cell cancer and other solid malignancies treated with sunitinib malate.

Authors:  Glenn Liu; Robert Jeraj; Matt Vanderhoek; Scott Perlman; Jill Kolesar; Michael Harrison; Urban Simoncic; Jens Eickhoff; Lakeesha Carmichael; Bo Chao; Rebecca Marnocha; Percy Ivy; George Wilding
Journal:  Clin Cancer Res       Date:  2011-10-28       Impact factor: 12.531

Review 4.  Normalization of the vasculature for treatment of cancer and other diseases.

Authors:  Shom Goel; Dan G Duda; Lei Xu; Lance L Munn; Yves Boucher; Dai Fukumura; Rakesh K Jain
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

5.  Assessing Oximetry Response to Chimeric Antigen Receptor T-cell Therapy against Glioma with 19F MRI in a Murine Model.

Authors:  Fanny Chapelin; Benjamin I Leach; Ruifeng Chen; Deanne Lister; Karen Messer; Hideho Okada; Eric T Ahrens
Journal:  Radiol Imaging Cancer       Date:  2021-01-22

Review 6.  The rationale and future potential of angiogenesis inhibitors in neoplasia.

Authors:  G Gasparini
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

7.  Pharmacological control of lung metastases of solid tumours by a novel ruthenium complex.

Authors:  G Sava; I Capozzi; K Clerici; G Gagliardi; E Alessio; G Mestroni
Journal:  Clin Exp Metastasis       Date:  1998-05       Impact factor: 5.150

Review 8.  Antiangiogenics: the potential role of integrating this novel treatment modality with chemoradiation for solid cancers.

Authors:  Dan G Duda; Rakesh K Jain; Christopher G Willett
Journal:  J Clin Oncol       Date:  2007-09-10       Impact factor: 44.544

9.  Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human breast cancer and ovarian cancer xenografts.

Authors:  Beverly A Teicher; Krishna Menon; Enrique Alvarez; Chuan Shih; Margaret M Faul
Journal:  Invest New Drugs       Date:  2002-08       Impact factor: 3.850

Review 10.  Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales.

Authors:  Asmaa E El-Kenawi; Azza B El-Remessy
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.